AOD-9604 · 10MG
Modified fragment of the C-terminus of human growth hormone (176-191) researched for lipolytic activity without GH-related side pathways.
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Modified fragment of the C-terminus of human growth hormone (176-191) researched for lipolytic activity without GH-related side pathways. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate. A downloadable Certificate of Analysis is available on request for every batch.
You may also like
Tesamorelin · 10MG
Clinically researched peptide studied for natural growth hormone release.
CJC-1295 + IPA Blend · 10MG
GHRH + GHRP research blend for growth axis studies.
IGF-1 LR3 · 1MG
Long-acting IGF-1 analog for cellular growth studies.